Sign inGet started

van Deventer Sander

Insider CIK 1543084 · ARGS Director, 10% owner · QURE EVP, Research & Product Dev., Director · HOOK Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HOOK HOOKIPA Pharma Inc. A Award2020-10-212020-10-232,485— $02,485SEC↗
HOOK HOOKIPA Pharma Inc. A Award deriv2020-06-182020-06-199,600— $09,600SEC↗
QURE uniQure N.V. A Award deriv2020-02-272020-03-0221,719— $021,719SEC↗
QURE uniQure N.V. A Award2020-02-272020-03-0212,380— $061,599SEC↗
QURE uniQure N.V. A Award2020-01-312020-01-316,092— $049,219SEC↗
QURE uniQure N.V. S Sale2020-01-282020-01-30923$62.10 $57.3K43,127SEC↗
QURE uniQure N.V. S Sale2020-01-282020-01-301,304$61.27 $79.9K44,050SEC↗
HOOK HOOKIPA Pharma Inc. A Award deriv2019-12-182020-01-039,600— $09,600SEC↗
QURE uniQure N.V. A Award2019-09-172019-09-1915,000— $045,354SEC↗
HOOK HOOKIPA Pharma Inc. A Award deriv2019-04-172019-04-2419,200— $019,200SEC↗
QURE uniQure N.V. S Sale2019-01-282019-01-301,358$31.31 $42.5K40,313SEC↗
QURE uniQure N.V. A Award deriv2019-01-252019-01-2918,325— $018,325SEC↗
QURE uniQure N.V. A Award2019-01-252019-01-2910,913— $041,571SEC↗
QURE uniQure N.V. A Award2019-01-252019-01-295,589— $030,658SEC↗
QURE uniQure N.V. S Sale2018-01-292018-01-315,985$18.53 $110.9K25,069SEC↗
QURE uniQure N.V. A Award deriv2018-01-262018-01-3020,788— $020,788SEC↗
QURE uniQure N.V. A Award2018-01-262018-01-307,795— $031,054SEC↗
QURE uniQure N.V. A Award deriv2017-09-202017-09-22150,000— $0150,000SEC↗
QURE uniQure N.V. A Award deriv2017-01-272017-01-3111,000— $016,000SEC↗
QURE uniQure N.V. A Award deriv2017-01-272017-01-3111,000— $011,000SEC↗
ARGS ARGOS THERAPEUTICS INC A Award deriv2017-01-192017-01-209,500— $09,500SEC↗
ARGS ARGOS THERAPEUTICS INC A Award2016-09-302016-10-032,263— $05,057SEC↗
ARGS ARGOS THERAPEUTICS INC P Buy deriv2016-08-022016-08-041,159,090— $01,159,090SEC↗
ARGS ARGOS THERAPEUTICS INC P Buy2016-08-022016-08-041,545,454— $06,199,961SEC↗
ARGS ARGOS THERAPEUTICS INC A Award2016-06-302016-07-051,427— $02,794SEC↗
ARGS ARGOS THERAPEUTICS INC P Buy deriv2016-06-292016-07-01991,964— $0991,964SEC↗
ARGS ARGOS THERAPEUTICS INC P Buy2016-06-292016-07-011,322,618— $04,654,507SEC↗
ARGS ARGOS THERAPEUTICS INC A Award deriv2016-06-132016-06-145,500— $05,500SEC↗
ARGS ARGOS THERAPEUTICS INC A Award2016-03-312016-04-041,367— $01,367SEC↗
ARGS ARGOS THERAPEUTICS INC P Buy deriv2016-03-142016-03-16661,309— $0661,309SEC↗
ARGS ARGOS THERAPEUTICS INC P Buy2016-03-142016-03-16881,745— $03,331,889SEC↗
ARGS ARGOS THERAPEUTICS INC A Award deriv2015-06-172015-06-195,500— $05,500SEC↗
ARGS ARGOS THERAPEUTICS INC A Award deriv2014-03-202014-03-2411,000— $011,000SEC↗
ARGS ARGOS THERAPEUTICS INC C Conversion deriv2014-02-122014-02-12984,840— $00SEC↗
ARGS ARGOS THERAPEUTICS INC C Conversion deriv2014-02-122014-02-121,428,888— $00SEC↗
ARGS ARGOS THERAPEUTICS INC C Conversion2014-02-122014-02-12984,840— $0984,840SEC↗
ARGS ARGOS THERAPEUTICS INC P Buy2014-02-122014-02-1236,416$8.00 $291.3K2,450,144SEC↗
ARGS ARGOS THERAPEUTICS INC C Conversion2014-02-122014-02-121,428,888— $02,413,728SEC↗